Combination Therapy of Fibroblast Growth Factor receptor (FGFR) / programmed Death 1 (PS 1) for the treatment of cancer

摘要

In the present description provides Combination Therapies for the treatment of cancer.In particular, the methods described relate to the treatment of cancer in a patient comprising administering an Antibody that blocks the interaction between pd-1 and pd-l1 and FGFR Inhibitor,Where are the Antibody that blocks the interaction between pd-1 and pd-l1 and FGFR inhibitor if there are one or more variants of biolgica FGFR present in a sample of the patient.